Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice

J Am Coll Cardiol. 2003 Dec 3;42(11):2000-6. doi: 10.1016/j.jacc.2003.07.021.

Abstract

Objectives: This study examined the role of angiotensin II (Ang-II) in a murine model of viral myocarditis.

Background: Ang-II plays an important role in the pathophysiology of various cardiovascular disorders. However, the role of Ang-II in inflammatory heart diseases is not known.

Methods: Four-week-old wild-type (WT) and Ang-II type 1 receptor (AT(1)R) knockout (KO) mice were inoculated with the encephalomyocarditis virus (EMCV). Survival, histopathology, expression of proinflammatory cytokines, and activity of nuclear factor-kappa B (NF-kB) in the heart were examined.

Results: The 14-day survival was significantly increased in KO compared with WT mice. Histopathologic scores for myocardial necrosis (0.86 +/- 0.69 vs. 2.44 +/- 0.88, p < 0.01) and cellular infiltration (0.86 +/- 0.38 vs. 2.33 +/- 0.50, p < 0.01) were lower in KO than in WT mice. The expression of tumor necrosis factor-alpha (TNF-alpha) was increased 43.2-fold, that of interleukin-1-beta (IL-1-beta) 45.8-fold, and the activity of NF-kB 2.24-fold by EMCV inoculation in WT mice (each p < 0.01), but not in KO mice (5.9-fold, 6.3-fold, and 1.12-fold, respectively, each p = NS). The AT(1)R blocker also significantly attenuated the expression of proinflammatory cytokines and the activation of NF-kB in virus-inoculated WT mice. Intravenous Ang-II injection enhanced the activation of NF-kB (2.28-fold, p < 0.01) and increased the expression of TNF-alpha (2.31-fold, p < 0.01) and IL-1-beta (2.45-fold, p < 0.01) in heart tissue of WT but not KO mice.

Conclusions: These results indicate that the AT(1)R signal is obligatory for the development of virus-induced myocardial injury through the proinflammatory action of Ang-II via the NF-kB/cytokine pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin II / physiology*
  • Angiotensin II Type 1 Receptor Blockers*
  • Animals
  • Benzimidazoles / pharmacology
  • Biphenyl Compounds / pharmacology
  • Cardiovirus Infections / etiology*
  • Cardiovirus Infections / pathology
  • Encephalomyocarditis virus* / isolation & purification
  • Heart / virology
  • Interleukin-1 / analysis
  • Interleukin-6 / analysis
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myocarditis / etiology*
  • Myocarditis / pathology
  • Myocardium / metabolism
  • NF-kappa B / analysis*
  • RNA, Messenger / analysis
  • Receptor, Angiotensin, Type 1 / physiology*
  • Tetrazoles*
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Biphenyl Compounds
  • Interleukin-1
  • Interleukin-6
  • NF-kappa B
  • RNA, Messenger
  • Receptor, Angiotensin, Type 1
  • Tetrazoles
  • Tumor Necrosis Factor-alpha
  • Angiotensin II
  • candesartan cilexetil